Jamieson Wellness Inc. (OTCMKTS:JWLLF) Short Interest Update

Jamieson Wellness Inc. (OTCMKTS:JWLLF) was the recipient of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 404,709 shares, an increase of 419.6% from the July 15th total of 77,891 shares. Based on an average daily volume of 12,221 shares, the days-to-cover ratio is presently 33.1 days.

Jamieson Wellness Price Performance

JWLLF stock traded up $0.01 during trading on Thursday, hitting $32.77. The company had a trading volume of 500 shares, compared to its average volume of 3,342. The company has a fifty day moving average price of $28.62 and a two-hundred day moving average price of $26.56. Jamieson Wellness has a fifty-two week low of $23.88 and a fifty-two week high of $32.78.

Analyst Ratings Changes

Several equities research analysts have issued reports on JWLLF shares. Citigroup lowered shares of Jamieson Wellness to a “hold” rating in a report on Friday, August 7th. Royal Bank Of Canada lowered shares of Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research report on Monday. National Bank Financial reissued an “outperform” rating on shares of Jamieson Wellness in a research note on Friday, June 26th. Finally, Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of Jamieson Wellness in a research report on Friday, May 8th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

About Jamieson Wellness

Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.

The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.